PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20043943-6	2010	Present study is an attempt to investigate the possible role of COX inhibitors (selective COX-2 inhibitor and preferential COX-2 inhibitors) against quinolinic acid-induced behavioral, oxidative stress and mitochondrial enzyme complex alterations in rats.	Quinolinic Acid	149-164	cytochrome c oxidase II, mitochondrial	Rattus norvegicus	90-95	
21237233-3	2011	Therefore, the present study has been designed to explore the neuroprotective potential of licofelone (dual COX-2/5-LOX inhibitor) against quinolinic acid induced Huntington like symptom in rats.	Quinolinic Acid	139-154	cytochrome c oxidase II, mitochondrial	Rattus norvegicus	108-113	
21362433-9	2011	Chronic treatment with the selective COX-2 inhibitors significantly restored the mitochondrial enzyme complex activities as well as attenuated TNF-alpha, IL-6 and caspase-3 levels as compared to the quinolinic acid treated group.	Quinolinic Acid	199-214	cytochrome c oxidase II, mitochondrial	Rattus norvegicus	37-42	
20043943-6	2010	Present study is an attempt to investigate the possible role of COX inhibitors (selective COX-2 inhibitor and preferential COX-2 inhibitors) against quinolinic acid-induced behavioral, oxidative stress and mitochondrial enzyme complex alterations in rats.	Quinolinic Acid	149-164	cytochrome c oxidase II, mitochondrial	Rattus norvegicus	123-128	
19927170-4	2009	The present study aims to elucidate the effects of caffeic acid (a specific inhibitor for LOX), rofecoxib (a specific inhibitor for COX-2), and their combination in ameliorating QA-induced neurotoxicity in rats.	Quinolinic Acid	178-180	cytochrome c oxidase II, mitochondrial	Rattus norvegicus	132-137